CFTR chloride channel is a molecular target of the natural cancer preventive agent resveratrol

Shuang Yang1, B O Yu, Yujie Sui

  • 1School of Life Sciences, Liaoning Provincial Key Laboratory of Biotechnology and Drug Discovery, Liaoning Normal University, Dalian, PR China.

Die Pharmazie
|October 24, 2013
PubMed

Insights

Resveratrol (RES) stimulates the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel, offering potential therapeutic applications for CFTR-related diseases like cystic fibrosis and constipation.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Physiology

Background:

  • Resveratrol (RES), a natural polyphenol, exhibits diverse health benefits.
  • Previous research indicated RES induces intestinal chloride secretion, but its molecular target remained unclear.
  • RES has been shown to stimulate cAMP-dependent chloride secretion in various cell types.

Purpose of the Study:

  • To investigate whether resveratrol (RES) directly targets and modulates the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel.
  • To identify the precise molecular mechanism underlying RES-induced chloride secretion.

Main Methods:

  • Cell-based fluorescent assays
  • Transepithelial short-circuit current measurements
  • Excised inside-out patch-clamp analysis
  • Ex vivo studies on rat colon

Main Results:

  • RES dose-dependently potentiated CFTR chloride channel activity.
  • RES-induced potentiation was reversed by CFTR-specific inhibitors (CFTR(inh)-172 and GlyH101).
  • RES stimulated transepithelial chloride secretion in CFTR-expressing cells and transmucosal chloride current in rat colon without elevating intracellular cAMP.

Conclusions:

  • Cystic fibrosis transmembrane conductance regulator (CFTR) is identified as a direct molecular target of resveratrol (RES).
  • RES may serve as a novel therapeutic lead compound for treating CFTR-related disorders such as cystic fibrosis and chronic constipation.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
84
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K